Chat with Filing

Ask questions about this document

Please log in or register to use the chat feature. Please register first.

RNS - IBU-tec advanced materials AG: IBU-tec supplies internationally active Asian pharmaceutical group

Company: IBU-tec advanced materials AG Date: 2020-06-30 Language: English Register to download

Loading document preview...

Document Preview Not Available

The file type (.html) cannot be displayed directly here.

Open Original File

Error loading document preview. Please try the 'Open Original File' link.

You're One Click Away From The Full Filing

Instantly access this document—and 2.8M more—for free. Select your preferred method:

Continue with Google Continue with Microsoft Continue with Facebook Continue with Amazon

 News Details

Corporate | 30 June 2020 10:00

#   

IBU-tec advanced materials AG: IBU-tec supplies internationally active Asian pharmaceutical group

DGAP-News: IBU-tec advanced materials AG / Key word(s): Miscellaneous  

30.06.2020 / 10:00  

The issuer is solely responsible for the content of this announcement.  

**IBU-tec supplies internationally active Asian pharmaceutical group**

**– Another pharmaceutical company places an order with IBU-tec for a drug to lower blood pressure**

**– IBU-tec sees further potential for distribution of the organotin catalyst**

**– More than 1.1 billion people worldwide suffer from high blood pressure**

  

Weimar, 30 June 2020 – IBU-tec advanced materials AG (“IBU-tec”, ISIN: DE000A0XYHT5) reports another successful sales performance in the pharmaceutical sector. For the first time, IBU-tec is supplying an internationally active pharmaceutical group from Asia with a chemical catalyst, to produce a generic drug to lower blood pressure. The first delivery in the double-digit ton range has already been completed and invoiced. Just recently, a further global pharmaceutical group extended an agreement for the purchase of this catalyst from IBU-tec unexpectedly. The organotin compound is a product of the IBU-tec subsidiary BNT Chemicals.

IBU-tec sees further sales and turnover potential for the distribution of the organotin catalyst in the coming years. In recent decades, the number of people suffering from high blood pressure has risen continuously. There are now more than 1.1 billion people suffering from hypertension worldwide, an increasing proportion of whom live in developing and emerging countries.

Ulrich Weitz, CEO of IBU-tec: “Our recent achievements in the pharmaceutical industry fill us with optimism. They also underpin the broad diversification of IBU-tec. After all, battery materials and air purification solutions, for example, are also areas in which we are strong. With our own products for the pharmaceutical industry, we are now tapping into further potential”.

**About IBU-tec**  

  

The IBU-tec Group develops and produces innovative materials of the highest quality for the industry. It combines unique, partly patent-protected thermal process engineering, with the process and material know-how of around 250 highly qualified employees.

The products are important components of battery materials for electric mobility and stationary energy storage, as well as solutions for air purification, resource conservation or the reduction of plastic packaging. IBU-tec is thus in a long-term position to respond to global megatrends, especially in the fields of climate and environmental protection. It has an international customer base ranging from innovative medium-sized companies to global corporations.

Further information can be found online at [www.ibu-tec.de](https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=redirect&url=3979e51539fe2fa352dc55f9c70047fa&application_id=1082033&site_id=news_data&application_name=news) .  

**Contact**  

  

edicto GmbH  

Axel Mühlhaus  

Eschersheimer Landstraße 42-44  

60322 Frankfurt  

Tel. +49 (0) 69-905505-52  

E-Mail: [IBU-tec@edicto.de](mailto:IBU-tec@edicto.de)

IBU-tec advanced materials AG  

Max Narr  

Hainweg 9-11  

99425 Weimar  

Tel.+49 (0) 151 67955683  

E-Mail: [max.narr@ibu-tec.de](mailto:max.narr@ibu-tec.de)

  

- - -

30.06.2020 Dissemination of a Corporate News, transmitted by DGAP – a service of EQS Group AG.  

The issuer is solely responsible for the content of this announcement.  

  

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.  

Archive at www.dgap.de  

- - -

|     |     |
| --- | --- |
| Language: | English |
| Company: | IBU-tec advanced materials AG |
|     | Hainweg 9-10 |
|     | 99425 Weimar |
|     | Germany |
| Phone: | +49 (0)3643 – 8649-0 |
| Fax: | +49 (0)3643 – 8649-30 |
| E-mail: | mail@ibu-tec.de |
| Internet: | www.ibu-tec.de |
| ISIN: | DE000A0XYHT5 |
| WKN: | A0XYHT |
| Indices: | Scale 30 |
| Listed: | Regulated Unofficial Market in Frankfurt (Scale), Tradegate Exchange |
| EQS News ID: | 1082033 |

  

|     |     |
| --- | --- |
|     |     |
| End of News | DGAP News Service |

![show this](https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1082033&application_name=news&site_id=news_data)